Articles About Psychiatry: Schizophrenia

Interventions for Weight Gain in Adults Treated With Novel Antipsychotics

Anxiety and Depression: Optimizing Treatments.

The Comparative Peripheral Anticholinergic-Like Adverse Event Profiles of Olanzapine and Risperidone.

Comparison of Risperidone and Olanzapine in Bipolar and Schizoaffective Disorders

A Case Report of Drug-Induced Dermatitis With Weekly Fluoxetine.

Prevalence of Metabolic Syndrome in Hispanic and Non-Hispanic Patients With Schizophrenia

The Metabolic Syndrome in Patients With Severe Mental Illnesses

CME Article: The Relation Between Body Fat Distribution and Cardiovascular Risk Factors in Patients With Schizophrenia: A Cross-Sectional Pilot Study

Variables Associated With General Practitioners' Knowledge About and Diagnostic Skills for Schizophrenia.

Careful Monitoring for Agranulocytosis During Carbamazepine Treatment

Change in Framingham Risk Score in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, 6-Week Trial of Ziprasidone and Olanzapine.

The 3-Year Clinical and Functional Course of Schizophrenia Among Individuals With and Without Diabetes at Study Entry

Lamotrigine-Induced Neutropenia in a Woman With Schizoaffective Disorder

Thyroid Myopathy With Rhabdomyolysis Presenting as Agitation: A Case Report

Clozapine-Induced Stuttering: A Case Series

Immediate and 8-Month Impact of a Medical Educational Course for General Practitioners on Knowledge About Schizophrenia and Its Treatment: Results of a 3-Phase Study From Brescia, Italy

Aripiprazole in Schizotypal Personality Disorder: A Case Report

Risperidone- and Aripiprazole-Induced Leukopenia: A Case Report

Prolactin Levels in Olanzapine Treatment Correlate With Positive Symptoms of Schizophrenia: Results From an Open-Label, Flexible-Dose Study

Partial Seizures With Secondary Generalization While on Treatment With Clozapine and Sertraline: A Case Report

Partial Adherence to Antipsychotic Medication Impacts the Course of Illness in Patients With Schizophrenia: A Review

Successful Use of Adjuvant Phytoestrogens in Schizoaffective Disorder: A Case Report

Case Report of Valproate-Induced Hypothermia in a Patient With Schizoaffective Disorder

Adjuvant Metformin Worsens Psychosis in Schizophrenia: A Case Report

Hospital Admission for Schizophrenia and Discharge Against Medical Advice in the United States

A Case of Lithium-Induced Symptomatic Hypercalcemia

A Positive Association Between Homeostasis Model Assessment of Insulin Resistance Score and the Trp64Arg Polymorphism of the β3-Adrenergic Receptor Gene in Schizophrenia Patients in Taiwan

Sodium Valproate–Induced Hyponatremia: A Case Report

Are Advanced Paternal Age and Point Mutation at Chromosome 4 Associated With Schizophrenia?

Atypical Antipsychotics and Insulin Resistance in Acute Mental Illness: A Case Series

A Case of Relapsing Priapism Associated With Long-Acting Injectable Risperidone

A Case of Cardiac Arrest and Pulmonary Embolism After Clozapine Titration

“I Choked My Wife Again!”—A Case Report

Treatment With Phytoestrogens for Depressive Symptoms in Late-Onset Schizophrenia: A Case Report

Schizoaffective Disorder With Missed Diagnosis of Acute Porphyria: A Case Report and Overview

A “Contemporary” Case of Frégoli Syndrome

Recurrent Episodes of Hypothermia With Psychiatric Medications: An Unsuspected Case of Primary Adrenal Insufficiency

Pharmacologic Treatment of First-Episode Schizophrenia: A Review of the Literature

Co-occurrence of Intermetamorphosis and Frégoli Syndrome in Schizophrenia: A Case Report

Sulfotransferase 4A1 Haplotype 1 (SULT4A1-1) Is Associated With Decreased Hospitalization Events in Antipsychotic-Treated Patients With Schizophrenia

Hypothermia Secondary to Ziprasidone Use in a Man With Schizophrenia

Dependence on Supratherapeutic Doses of Modafinil: A Case Report

Beneficial Effects of the Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia in Patients With Postpsychotic Depressive Disorder of Schizophrenia: Report of 5 Cases

Olanzapine-Associated Leukopenia and Thrombocytopenia Managed With Lithium in a Patient Who Developed Leukopenia With Clozapine in the Past: A Case Report

Importance of Gender in the Treatment of Schizophrenia

Self-Disturbance in Schizophrenia: A Phenomenological Approach to Better Understand Our Patients

Treatment of Hyperprolactinemia and Gynecomastia With Adjunctive Aripiprazole in 2 Men Receiving Long-Acting Injectable Antipsychotics

Effect of Probiotic Supplementation on Schizophrenia Symptoms and Association With Gastrointestinal Functioning: A Randomized, Placebo-Controlled Trial

Lithium-Induced Transient Euthyroid Hyperthyroxinemia: A Case Report

Ranitidine, Metformin, and Topiramate: Managing Weight Gain in a Clozapine-Treated Patient With Schizoaffective Disorder

Resolution of Positive Symptoms of Schizophrenia After Traumatic Brain Injury

A Case Report of Clozapine-Induced Severe Gastrointestinal Hypomotility

Outpatient Metformin Management of Obese Individuals With Schizophrenia

Selective Immunoglobulin M Deficiency Among Clozapine-Treated Patients: A Nested Case-Control Study

Frequent Comorbidity and Predictors of Social Anxiety in Persons With Schizophrenia: A Retrospective Cohort Study

Catatonia in the Setting of Hyponatremia

Disequilibrium of Cytokine Serum Levels in Veterans With Chronic Schizophrenia Medicated With Antipsychotics: Association With Measures of Excitement and Hostility

Benzodiazepine Maintenance Treatment in Schizophrenia

Long-Term Treatment of Clozapine-Induced Leukopenia With Lithium: Fast-Onset Agranulocytosis Following Lithium Discontinuation

Factors Differentiating Childhood-Onset and Adolescent-Onset Schizophrenia: A Claims Database Study

Dose-Dependent Clozapine-Induced Supraventricular Tachycardia

Serotonin Syndrome: Prophylactic Treatment With Cyproheptadine

A Case of Mistaken Identity: Akathisia or Lithium-Induced Hyperthyroidism?

Psychoactive Substance Use by Adults With Schizophrenia Before and During Cannabis Withdrawal

Acute Urinary Retention and Catatonia in a Schizophrenic Male Patient

Long-Acting Injectable Antipsychotics for Schizophrenia: Sociodemographic Characteristics and Treatment Adherence

Use of Omega-3 Polyunsaturated Fatty Acids as Augmentation Therapy in Treatment-Resistant Schizophrenia

Lurasidone-Induced Dystonia

Clozapine-Induced Procalcitonin Elevation

Untreated Dyslipidemia in Lebanese Patients With Schizophrenia

An Unmet Need: A Clozapine-Induced Myocarditis Screening Protocol

Successful Readministration of Clozapine in a Patient With a History of Clozapine-Induced Elevation of Creatine Phosphokinase

Paliperidone-Induced Hyponatremia

Psychostimulant Use in Schizophrenia for Treatment of Negative Symptoms and Weight Loss

Short Sleep in Patients With Chronic Paranoid Schizophrenia

Late-Onset Rhabdomyolysis Associated With an Intramuscular Injection of Fluphenazine Decanoate

Bright Light Therapy for Negative Symptoms

Medication Adherence Decisions in Patients With Schizophrenia

Unexpected Falls During Clozapine Treatment Explained by Myoclonus

Successful Treatment of Catatonia with Methylphenidate in a 25-Year-Old Patient With Schizophrenia